Home » Topics » BioWorld

BioWorld
RSS

AFFYMAX COMPLETES $80 MILLION IPO

Dec. 18, 1991

SYNERGEN RAISES $225.4M IN FINANCING

Dec. 18, 1991

PROTEIN DESIGN FILES FOR IPO

Dec. 18, 1991

IMMUNEX PATENT FOR FUSION MOLECULE

Dec. 18, 1991

CHIRON TO RECEIVE BRITISH PATENT

Dec. 18, 1991

MMD BUYS STAKE IN IMMULOGIC

Dec. 18, 1991

IMMUNE RESPONSE FILES IND

Dec. 18, 1991

GENTA RAISES $25 MILLION IN IPO

Dec. 18, 1991

MS THERAPY EFFECTIVE IN MOUSE MODEL

Dec. 18, 1991

STEALTH IMPROVES DRUG DELIVERY

Dec. 17, 1991

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...